Terms: = Thyroid cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Prognosis
5 results:
1. Identification and validation of N
Li J; Zheng L; Song L; Dong Z; Bai W; Qi L
J Cell Mol Med; 2024 Jan; 28(2):e18067. PubMed ID: 38071502
[TBL] [Abstract] [Full Text] [Related]
2. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
3. Clinical impact of pretreatment albumin-globulin ratio in patients with colorectal cancer: A meta-analysis.
Ma JY; Liu G; Pan LZ; Hu M; Zhu ZZ
Medicine (Baltimore); 2022 May; 101(20):e29190. PubMed ID: 35608420
[TBL] [Abstract] [Full Text] [Related]
4. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract] [Full Text] [Related]
5. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis.
Ruiz J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Endocrinol Diabetes Nutr (Engl Ed); 2020 May; 67(5):317-325. PubMed ID: 31882257
[TBL] [Abstract] [Full Text] [Related]